The anticoagulated patient presenting for cataract surgery presents many dilemmas for anaesthetist and surgeon alike. Current evidence suggests that warfarin therapy significantly improves prognosis in patients with atrial fibrillation with coexisting cerebrovascular disease, and those with non-tissue prosthetic heart valves. Inadequate anticoagulation in these groups exposes them to higher risk of systemic embolic complications, which are frequently devastating.
The management of the patient receiving anticoagulant therapy and requiring cataract surgery can be challenging. There is a need to consider the underlying medical condition for which anticoagulant therapy was indicated and whether ceasing anticoagulation will significantly increase the risk of thromboembolic complications. At the same time, one has to weigh up the additional implications accompanying different local and general anaesthetic techniques and surgery, not only in patients with existing anticoagulation, but also in patients in which reversal of anticoagulation might be attempted.
INDICATIONS FOR ANTICOAGULANT THERAPY
The two most common indications for anticoagulant therapy are non-rheumatic atrial fibrillation (NRAF), and presence of a prosthetic heart valve. Other less common conditions include ischaemic heart disease, peripheral vascular disease and recurrent venous thromboembolism.
NRAF has a prevalence of 0.04% in patients less than 50 years, increasing up to 9% in the age range of 62 to 90 years 1 . Embolic complications from NRAF account for 15% of all strokes 2 , but proportionately 1.5% of all strokes are associated with NRAF at the age range 50 to 59 years, while 25% of all strokes are associated with NRAF at age 80 to 89 years 3 . Thus the risk of stroke in patients with NRAF increases with age.
The presence of NRAF without comorbidities such as structural heart disease, hypertension, diabetes, thyrotoxicosis or previous stroke confers a 1.3 to 1.4% risk per year of embolic stroke 3 . However "lone atrial fibrillation" represents 2 to 4% of the population of all people with NRAF 3 , hence the typical patient presenting for eye surgery is likely to be both older and have comorbid conditions in association with NRAF 4 . Anticoagulant therapy is common in this group of patients. The Framingham study found that the risk of stroke in all people with NRAF was 4.2% per year 4 . Given that approximately 97% of people with NRAF have comorbid disease 4 , this rate would represent the average risk to a typical patient. It is common practice to stop anticoagulation for surgery in these groups for variable periods of 3 to 14 days perioperatively. Among this group, those who have had a previous stroke and are on anticoagulant therapy have a recurrent stroke rate which increases to 6 to 8.1% in the next 1.7 to 2.3 years 2 . If they are not receiving anticoagulant therapy the risk of recurrence increases to 9.3 to 13% per year 2 . This group appears to be at particular risk with cessation of anticoagulation.
Several well-conducted studies [2] [3] [4] [5] have highlighted the effectiveness of warfarin anticoagulation, showing significant decreases in thromboembolic events when compared with aspirin alone, or placebo. This is particularly so in older patients and in those with comorbid disease, especially past history of stroke. Additionally, when one considers that the patients with NRAF receiving anticoagulant therapy in these studies were particularly closely monitored, the true incidence for thromboembolic complications in a less tightly monitored patient presenting for eye surgery may be higher.
Patients with a prosthetic heart valve and on anticoagulant therapy represent another large group who present for eye surgery. This group need precise control of anticoagulation in order to avoid thromboembolic and bleeding complications. Cannegieter et al 7 Other factors that impact on complications in patients with prosthetic heart valves include age (both thromboembolism and bleeding are more likely in older people), and the number and location of valve prostheses (those with two valves and those with mitral valves as opposed to aortic valves are more likely to suffer thromboembolic complications) 7 .
ANAESTHESIA AND EYE SURGERY IN THE ANTICOAGULATED PATIENT
Patterns of anaesthesia for cataract surgery have undergone great changes in recent times and are now quite heterogeneous. Today's practice trends more towards regional anaesthesia but incorporates general anaesthesia, retrobulbar and peribulbar blocks, sub-Tenon's block and topical anaesthesia. Where peribulbar and retrobulbar blocks are used, there is great variety: needles used range from 23 to 30 gauge, their lengths range from 25 to 32 mm, and there are differing injection sites, i.e. single lower lateral injection only, or dual with lower lateral injection combined with either superomedial or medial injection.
It is difficult to identify the reason why no large randomized studies exist that report the risks associated with local anaesthesia in the anticoagulated patient having cataract surgery. Perhaps the heterogeneity of recent practices may partly account for this, together with the fact that patients taking anticoagulant medications represent a subpopulation of all patients presenting for cataract surgery. There are also few specialist eye hospitals that can draw large populations of patients having cataract surgery.
Several observational studies where large numbers of peribulbar and retrobulbar eye blocks have been performed in all patients having cataract surgery have identified a mix of technical and patient factors that are associated with bleeding, particularly retrobulbar haemorrhage [8] [9] [10] [11] . Bleeding is considered to be reduced with use of peribulbar [8] [9] [10] [11] [12] [13] [14] as opposed to retrobulbar blockade, use of smaller gauge and shorter length needles (less than 25 mm), and use of the medial canthus injection site as opposed to the superior medial injection site 12 .
Other factors which may also increase the risk of bleeding include anticoagulant therapy that has been ceased, other therapies such as steroids, NSAIDS, newer antiplatelet agents, increasing age, presence of coexisting haematological disease and presence of coexisting vascular disease 8, 12 .
Recent reported rates of retrobulbar haemorrhage in all patient populations have varied from 0.07% in a series of 16,224 peribulbar blocks using 23 gauge 25-32 mm needles 9 , to 0.44% in a series of 12,500 retrobulbar blocks using 25 gauge 32 mm needles 10 .
Alternative local anaesthetic approaches are worthy of further discussion. Sub-Tenon's blockade is widely practised, with many practitioners reporting minimal risk of haemorrhage. Greenbaum 15 reported that there was no record of retrobulbar haemorrhage or any other haemorrhagic complication in 40,000 sub-Tenon's blocks performed to 1997. However, there is theoretical risk of bleeding from vortex veins traversing the space 16, 17 . Combinations of topical and subconjunctival anaesthesia also carry less direct risk of deep haemorrhage but are only appropriate for patients who can cope with strong stretch sensations from the ciliary muscle, and for surgeons who can modify their technique to minimize stimulation of these structures, and also operate on a mobile eye 18, 19 .
Data on anticoagulated patients having eye blocks for cataract surgery are limited. There is one study where four of ten patients having cataract surgery had their warfarin continued and had retrobulbar blocks as the mode of anaesthesia, and had no retrobulbar haemorrhages recorded 20 . In another series of 60 patients who suffered retrobulbar haemorrhage after retrobulbar blockade using 25 gauge 32 mm needles 23 , 30% were on warfarin or NSAIDS as opposed to 20% in a control group having the same anaesthetic blocks, who did not have retrobulbar haemorrhages. This corresponds to an increased risk (approximately 1.7) for retrobulbar haemorrhage in a patient who has been taking warfarin or NSAIDS. Interestingly, we are told that patients on anticoagulants usually had their medication ceased prior to surgery unless the internists decided that there was a contraindication to cessation of therapy. Unfortunately there are no more details, so we have to assume that the population was a mixed one, consisting mainly of patients having their anticoagulation ceased.
Another study of 49 patients who were on warfarin up until surgery, and who had local anaesthesia (specific techniques not mentioned), reported no retrobulbar haemorrhages 22 . Patients in this study had variable prothrombin times on the day of surgery, with 29 of 49 patients having times in the normal range. This may reflect the common situation where the anticoagulated patient may have variable warfarin effectiveness, probably secondary to drug interactions, and where their anticoagulation status may be less tightly monitored.
A consistent finding in three studies 21, 23, 24 is the greater risk of haemorrhage in patients who are on anticoagulants and have had their anticoagulation stopped prior to surgery, compared with patients not on anticoagulant therapy. These complications included hyphaema, subconjunctival haemorrhage, retrobulbar haemorrhage and vitreous haemorrhage, and the combined rate varied between 6 and 12% of patients.
Anticoagulated patients may be susceptible to haemorrhagic complications for a number of reasons. First, the effect of warfarin is extremely unpredictable 25 , varying with both increasing age (where levels fall away more slowly), and with coexistent drug administration (where levels can rise or fall). Second, coagulation status is not accurately reflected by tests such as prothrombin time 21 , as the vitamin K-dependent coagulation factors are re-synthesised at varying rates; for example factor VII is resynthesized approximately ten times more quickly than factor II.
In fact the cessation of warfarin may predispose to hypercoagulable states as has been suggested by two surveys 26, 27 . In the first 27 , conducted among 135 ophthalmologists, the thrombotic risks may have been overstated as there was not only cessation of anticoagulation but also use of fresh frozen plasma, vitamin K and platelet transfusions. Among the 100 ophthalmologists who ceased anticoagulation, there were six strokes (two leading to death), one deep venous thrombosis and one pulmonary embolus. Alarmingly, in this same group there were also 16 haemorrhagic complications, including 12 hyphemae and one retrobulbar haemorrhage. This contrasted with 10 ophthalmologists who maintained anticoagulant therapy, with no haemorrhages or thromboembolic complications reported.
The second study surveyed 100 ophthalmologists in the Netherlands 26 , 57 of whom ceased anticoagulant therapy two to three days before eye surgery and recommenced anticoagulation one to two days after surgery. From this group, there were nine thromboembolic complications (one stroke and eight peripheral thromboses), while only one haemorrhage was reported.
Such high rates of thromboembolic complications are not accounted for by the natural history of the conditions for which warfarin is being administered, given it was ceased for such short periods of time. Cessation of warfarin may set up a rebound hypercoagulable state 25 , through the interruption of the equilibrium between the vitamin K-dependent coagulant factors, and protein C and protein S whose circulating anticoagulant actions are also inhibited by warfarin. In fact it is proposed that protein C and protein S recover much more slowly than the vitamin K-dependant coagulant factors, accounting for this state 25 . The warfarinized patient having cataract surgery and having warfarin ceased is at greater risk of thromboembolic complications due to the natural history of the untreated underlying disease for which warfarin is administered and also due to a transient effect of warfarin as it is wearing off. Paradoxically, the warfarinized patient having warfarin ceased prior to surgery is also susceptible to haemorrhagic complications in this same situation. Both these types of complications appear to occur more frequently, when compared to non-anticoagulated patients having cataract surgery. Thromboembolic complications are often catastrophic, exposing the patient to death or significant disability: two of the nine patients in the Dutch survey died and another three sustained lasting neurological deficits 26 , while the U.S. survey 27 reported two deaths and seven cardiovascular complications from 102 patients.
Retrobulbar haemorrhage usually carries a good prognosis for visual acuity. In 60 cases of retrobulbar haemorrhage after local anaesthetic blockade (in a population including anticoagulated patients), 57 were managed sufficiently well to enable surgery to proceed, while the remaining three were operated on successfully at a later date, all by the same surgeon 23 . Long-lasting effects involving acuity appeared to be infrequent and difficult to attribute solely to the retrobulbar haemorrhage. The three patients who had an acuity of 20/40 or less had confounding factors (all three had some degree of macular degeneration, while one additionally had corneal scarring and retinal detachment). In another series, 55 patients with retrobulbar haemorrhage were compared to matched controls and found to have the same longterm prognosis for visual acuity. In the two surveys above, the first represented the experience of a single surgeon, while the second involved multiple surgeons.
Other complications such as hyphaema, lid ecchymosis, and sub-conjunctival haemorrhage have very good prognosis, with most resolving spontaneously 22, 25 . Choroidal, vitreoretinal and expulsive haemorrhages occur more rarely and usually have poorer prognoses for visual acuity 28 . These conditions are linked with multiple factors including coexistent systemic and ocular diseases, anticoagulation therapy, type and technique of surgery, retrobulbar haemorrhage and sudden rises in intraocular pressure 28 . These complications appear to be no greater with any particular anaesthetic technique, whether general or local. There are implications for anaesthetic care however, as the mechanism for these haemorrhages includes sudden rises in intraocular pressure on a background of choroidal vessel fragility. This may implicate other coexistent conditions such as airway disease and smoking, and also airway complications as might occur with airway manipulation in general anaesthesia and also local anaesthesia utilizing deep planes of sedation.
The association of vitreoretinal haemorrhage with retrobulbar haemorrhage is through the mechanism of inadequate relief of orbital pressure via venous tamponade and sudden compression of choroidal vessels 28 . When one considers that retrobulbar haemorrhage is in fact an uncommon event, even in those receiving anticoagulant therapy, and that choroidal haemorrhage is an uncommon complication of retrobulbar haemorrhage, this would represent a small overall risk to the patient.
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SUMMARY OF MAJOR STUDIES

RECOMMENDATIONS
The current evidence in the literature regarding the anticoagulated patient presenting for eye surgery is of variable quality. Evidence justifying need for warfarin in NRAF with stroke and heart valve prosthesis is based on well structured randomized trials. The remaining evidence, despite showing some consistent findings, is mostly derived from nonrandomized observational studies. Hence, given what is currently known, the following recommendations can be made.
NRAF or presence of a heart valve prosthesis are common indications for anticoagulation. In the preoperative period it would seem prudent to continue anticoagulation and confirm that the INR level is therapeutic. This is particularly so in the groups with NRAF and known cerebrovascular disease, and all patients with non-tissue valve prostheses, as these groups are at highest risk of thromboembolic complications with cessation of warfarin.
A significant accompaniment to this management is a balanced discussion of risk versus benefit with the 16 
A. KONSTANTATOS
Anaesthesia and Intensive Care, Vol. 29, No. 1, February 2001 10, 11 if a retrobulbar block is performed, irrespective of whether warfarin is continued or ceased. It might be prudent to also inform them that risk of retrobulbar haemorrhage may approach zero 15 if sub-Tenon's block or topical anaesthesia is performed, but one would have to take patient and surgical acceptance into account. There is also a need to discuss the consequences of retrobulbar haemorrhage if it should occur, namely a small risk of significant loss of visual acuity of (2 to 5%) 23 coupled with a greater risk of intervention (lateral canthotomy) and deferral of surgery. This consideration should be balanced with the possible sequelae of a stroke.
Additionally, the risks of general anaesthesia should be discussed. Recent local estimates of overall risk of anaesthetic related mortality are 1 in 63,000 29 . Obviously, in anticoagulated patients with coexistent cardiovascular and other diseases, these risks may be higher.
If a peribulbar or retrobulbar technique is chosen, a single inferotemporal peribulbar approach utilizing a 27 gauge (or smaller) needle of 25 mm length (or less) may represent the safest practice [8] [9] [10] [11] [12] [13] [14] . This should only be performed with the surgeon immediately available, as in the event of a suspected retrobulbar haemorrhage he/she can act swiftly to decompress the eye and improve the prognosis. Alternative local anaesthetic techniques such as sub-Tenon's block or topical anaesthesia appear safer still and may be appropriate for carefully chosen patients provided the surgeon is able to operate under such conditions. Finally there is merit in establishing a referral centre incorporating anaesthetists and ophthalmologists who can deal with anticoagulated patients presenting for eye surgery. Ideally it should function with a pre-anaesthetic facility given the degree of patient education and preparation necessary. It would also provide an opportunity for large-scale systematic collection of data so that future practice can be more reliably guided.
